4[1]Flieger D,Klassert C,Hainke S,et al.Phase Ⅱ Clinical Trial for Prevention of Delayed Diarrhea with Cholestyramine/Levofloxacin in the Second-Line Treatment with lrinotecan Biweekly in Patients with Metastatic Colorectal Carcinoma[J].Oneology,,2007,72:10-16.
5[2]Baron JA,Sandier RS,Btesalier RS,et al.A randomized thai of rofecoxib for the chemoprevention of eolorectal adenomas[J].Gastroenterology,2006,131:1674-1682.
6[3]Takada H,Ohsawa T,Iwamoto S,et al.Changing site diseriptinn of colorectal cancer in Japan[J].Dis Colon Rectum,2002,45:12.49-133.
7[4]Uehara K,Nakaoishi Y,Shimoda T,et al.Clinieopathological significance of microsopic abscess formation at the invasive margin of advanced low rectal cancer[J].Br J Surg,2007,94:239-243.
8[5]Jessup JM,Stewart A,Greene FL,et al.Adjuvant chemotherapy for stage Ⅲ colon cancer:implications of race/ethnicity,age,and differentiation[J].JAMA,2005,294:2703-2711.
9[7]Chun HK,Choi D,Kim MJ,el al.Preoperative staging of rectal cancer:comparison of 3-T high-field MRI andendorectal sonography[J].A JR Am J Roentgenol,2006,187:1557-1562.
10[8]da Silva RG,Sugarbaker PH.Analysis of prognostic factors in seventy patients having a completecytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from eolorectal cancer[J].J Am Coll Surg,2006,203:878-886.
